{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["OpenSAFELY Collaborative"],"funding":["Medical Research Council","National Institute for Health Research (NIHR)","Wellcome Trust"],"pagination":["e066164"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9890277"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13(1)"],"pubmed_abstract":["<h4>Objective</h4>To characterise factors associated with COVID-19 vaccine uptake among people with kidney disease in England.<h4>Design</h4>Retrospective cohort study using the OpenSAFELY-TPP platform, performed with the approval of NHS England.<h4>Setting</h4>Individual-level routine clinical data from 24 million people across GPs in England using TPP software. Primary care data were linked directly with COVID-19 vaccine records up to 31 August 2022 and with renal replacement therapy (RRT) status via the UK Renal Registry (UKRR).<h4>Participants</h4>A cohort of adults with stage 3-5 chronic kidney disease (CKD) or receiving RRT at the start of the COVID-19 vaccine roll-out was identified based on evidence of reduced estimated glomerular filtration rate (eGFR) or inclusion in the UKRR.<h4"],"journal":["BMJ open"],"pubmed_title":["Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study."],"pmcid":["PMC9890277"],"funding_grant_id":["20059","MR/W016729/1","MC_PC_20059","222097/Z/20/Z","MC_PC-20059","COV-LT2-0073","HDR-9002","MR/V015757/1","MC_PC_20059-5","MC_PC_20030","NIHR135559","MR/V015737/1","MR/W021420/1"],"pubmed_authors":["Sterne JA","Harper S","Carr EJ","Parry J","Williamson EJ","Steenkamp R","Tazare J","Horne EM","Tomlinson LA","Goldacre B","Mahalingasivam V","Willicombe M","Zheng B","Hulme WJ","Loud F","Nitsch D","Parker EP","Curtis HJ","Nab L","Hester F","Green AC","OpenSAFELY Collaborative","Lyon S","Bates C","Mehrkar A","Fisher L","Cockburn J","Santhakumaran S","Walker AJ"],"additional_accession":[]},"is_claimable":false,"name":"Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.","description":"<h4>Objective</h4>To characterise factors associated with COVID-19 vaccine uptake among people with kidney disease in England.<h4>Design</h4>Retrospective cohort study using the OpenSAFELY-TPP platform, performed with the approval of NHS England.<h4>Setting</h4>Individual-level routine clinical data from 24 million people across GPs in England using TPP software. Primary care data were linked directly with COVID-19 vaccine records up to 31 August 2022 and with renal replacement therapy (RRT) status via the UK Renal Registry (UKRR).<h4>Participants</h4>A cohort of adults with stage 3-5 chronic kidney disease (CKD) or receiving RRT at the start of the COVID-19 vaccine roll-out was identified based on evidence of reduced estimated glomerular filtration rate (eGFR) or inclusion in the UKRR.<h4","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan","modification":"2025-04-21T16:08:05.924Z","creation":"2025-04-21T16:08:05.924Z"},"accession":"S-EPMC9890277","cross_references":{"pubmed":["36720568"],"doi":["10.1136/bmjopen-2022-066164"]}}